Shanghai Hengrui Pharmaceutical Co., Ltd.;Jiangsu Hengrui Medicine Co., Ltd.
发明人:
WU, Tingting,LI, Hao,LIU, Xun,FU, Yayuan
申请号：
AU2018391217
公开号：
AU2018391217A1
申请日:
2018.12.21
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
Disclosed are a lymphocyte-activation gene 3 (LAG-3) antibody pharmaceutical composition and the use thereof. The pharmaceutical composition comprises a LAG-3 antibody or an antigen-binding fragment thereof in an acetate buffer or in a histidine salt buffer. The pharmaceutical composition may also comprise sugar, non-ionic surfactant and other excipients.
